Investigation Report on China Voriconazole Market, 2010-2019
Description
In recent years, the abuse of antibiotics has resulted in the mass generation of drug-resistant strains and the increased incidence of fungal infection deep seated in tissues. On the other hand, as the number of patients with immune deficiency increases and people take human organ transplant, interventional treatment and chemotherapeutic agents for tumor, the incidence of fungal infection has gone up gradually, which has boosted the fast growth of anti-fungal drugs.
That the incidence of fungal infection has reached 80% in today’s China has driven the rapid growth of anti-fungal drug market. The overall market scale of domestic anti-fungal infection drugs has hit over CNY 5 billion, of which drugs for deep-seated fungal infection take up over 60%.
Voriconazole, a kind of triazole, was developed by Pfizer and came into the US market in 2002. In 2005, voriconazole was introduced into China with Pfizer and its division Upjohn taking up more than 50% of the market. Currently, local firms making voriconazole are Ebang Pharmaceutical, Sichuan Beauty Sport Huakang Pharmaceutical Co., Ltd, Jincheng HEALTH Pharmaceutical Co., Ltd and GeneTech Pharm which occupy the rest Chinese market. According to CRI’s investigation, Voriconazole develops fast after entering China with annual sales rising from CNY 1.14 million in 2005 to CNY 963 million in 2014 and CAGR reaching up to 439.11%.
According to the social epidemiological study, fungal infection is a disease featuring relatively high incidence and reinfection rate. Therefore, anti-fungal drugs enjoy good market prospects.
Readers can get at least the following information through this report:
In recent years, the abuse of antibiotics has resulted in the mass generation of drug-resistant strains and the increased incidence of fungal infection deep seated in tissues. On the other hand, as the number of patients with immune deficiency increases and people take human organ transplant, interventional treatment and chemotherapeutic agents for tumor, the incidence of fungal infection has gone up gradually, which has boosted the fast growth of anti-fungal drugs.
That the incidence of fungal infection has reached 80% in today’s China has driven the rapid growth of anti-fungal drug market. The overall market scale of domestic anti-fungal infection drugs has hit over CNY 5 billion, of which drugs for deep-seated fungal infection take up over 60%.
Voriconazole, a kind of triazole, was developed by Pfizer and came into the US market in 2002. In 2005, voriconazole was introduced into China with Pfizer and its division Upjohn taking up more than 50% of the market. Currently, local firms making voriconazole are Ebang Pharmaceutical, Sichuan Beauty Sport Huakang Pharmaceutical Co., Ltd, Jincheng HEALTH Pharmaceutical Co., Ltd and GeneTech Pharm which occupy the rest Chinese market. According to CRI’s investigation, Voriconazole develops fast after entering China with annual sales rising from CNY 1.14 million in 2005 to CNY 963 million in 2014 and CAGR reaching up to 439.11%.
According to the social epidemiological study, fungal infection is a disease featuring relatively high incidence and reinfection rate. Therefore, anti-fungal drugs enjoy good market prospects.
Readers can get at least the following information through this report:
- market size of voriconazole in China
- major manufacturers of voriconazole in Chinese market and their market share
- retail price of voriconazole in Chinese market
- market outlook of voriconazole in China
- manufacturers of anti-fungal drugs
- investors/ research institutions interested in Chinese medicine market
- any interest in Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF VORICONAZOLE
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF VORICONAZOLE IN CHINA
2.1 Patent and Approval Status of Voriconazole in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF VORICONAZOLE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF VORICONAZOLE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF VORICONAZOLE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF VORICONAZOLE IN CHINESE HOSPITALS IN 2014
6.1 Livzon (Trade Name: Li Fu Kang)
6.3 Sichuan Beauty Sport Huakang Pharmaceutical Co., Ltd (Trade Name: Hui De Li Kang)
6.4 Jincheng HEALTH Pharmaceutical Co., Ltd (Trade Name: Di Er Da Ning)
6.5 Huasun (Trade Name: Lai Li Kang)
6.6 Pharmacia & Upjohn (the US) (Trade Name: VFEND)
6.7 Ebang Pharmaceutical (Trade Name: Hui Bang Ling)
6.8 Pfizer (Germany) (Trade Name: VFEND)
7 MAJOR MANUFACTURERS OF VORICONAZOLE IN THE CHINESE MARKET, 2010-2014
7.1 GeneTech Pharm
7.2 Sichuan Beauty Sport Huakang Pharmaceutical Co., Ltd
7.3 Jincheng HEALTH Pharmaceutical Co., Ltd
7.4 Ebang Pharmaceutical
7.5 Pfizer
8 MARKET OUTLOOK OF VORICONAZOLE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF VORICONAZOLE IN CHINA
2.1 Patent and Approval Status of Voriconazole in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF VORICONAZOLE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF VORICONAZOLE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF VORICONAZOLE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF VORICONAZOLE IN CHINESE HOSPITALS IN 2014
6.1 Livzon (Trade Name: Li Fu Kang)
6.3 Sichuan Beauty Sport Huakang Pharmaceutical Co., Ltd (Trade Name: Hui De Li Kang)
6.4 Jincheng HEALTH Pharmaceutical Co., Ltd (Trade Name: Di Er Da Ning)
6.5 Huasun (Trade Name: Lai Li Kang)
6.6 Pharmacia & Upjohn (the US) (Trade Name: VFEND)
6.7 Ebang Pharmaceutical (Trade Name: Hui Bang Ling)
6.8 Pfizer (Germany) (Trade Name: VFEND)
7 MAJOR MANUFACTURERS OF VORICONAZOLE IN THE CHINESE MARKET, 2010-2014
7.1 GeneTech Pharm
7.2 Sichuan Beauty Sport Huakang Pharmaceutical Co., Ltd
7.3 Jincheng HEALTH Pharmaceutical Co., Ltd
7.4 Ebang Pharmaceutical
7.5 Pfizer
8 MARKET OUTLOOK OF VORICONAZOLE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
SELECTED CHARTS
Chart Patent Status of Voriconazole in China
Chart Approval Status of Voriconazole in China
Chart Sales Status of Voriconazole in Chinese Market
Chart Sales Value of Voriconazole in China, 2010-2014
Chart Sales Value of Voriconazole in Some Regions in China, 2010-2014
Chart Sales Volume of Voriconazole in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Voriconazole for Sales Value in Chinese Market, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Upjohn (the US) in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Pfizer (Germany) in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Huasun in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Sichuan Beauty Sport Huakang in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Ebang in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Voriconazole for Sales Volume, 2010-2014
Chart Sales Value and Market Share of Voriconazole Injection in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Tablets in China, 2010-2014
Chart Price of Voriconazole Made by Livzon in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Huasun in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Pharmacia & Upjohn (the US) in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Ebang Pharmaceutical in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Pfizer (Germany) in Some Chinese Cities in 2014
Chart Patent Status of Voriconazole in China
Chart Approval Status of Voriconazole in China
Chart Sales Status of Voriconazole in Chinese Market
Chart Sales Value of Voriconazole in China, 2010-2014
Chart Sales Value of Voriconazole in Some Regions in China, 2010-2014
Chart Sales Volume of Voriconazole in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Voriconazole for Sales Value in Chinese Market, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Upjohn (the US) in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Pfizer (Germany) in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Huasun in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Sichuan Beauty Sport Huakang in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Made by Ebang in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Voriconazole for Sales Volume, 2010-2014
Chart Sales Value and Market Share of Voriconazole Injection in China, 2010-2014
Chart Sales Value and Market Share of Voriconazole Tablets in China, 2010-2014
Chart Price of Voriconazole Made by Livzon in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Huasun in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Pharmacia & Upjohn (the US) in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Ebang Pharmaceutical in Some Chinese Cities in 2014
Chart Price of Voriconazole Made by Pfizer (Germany) in Some Chinese Cities in 2014
